Diabetes News and Research

Latest Diabetes News and Research

Food sustainability incorporated in only 20% of European food-based dietary guidelines

The health of the planet and that of humankind are profoundly interconnected: the way we feed ourselves has a significant impact upon both our own health and that of the environment.

8 Nov 2022

Study helps understand the basis of sex differences in SARS-CoV-2 infection

Significant immunological differences between young men and women were shown to mediate sex differences in the responses to the virus that causes COVID-19, according to a collaborative study of nearly 3,000 young, healthy members of the U.S. Marine Corps.

8 Nov 2022

Female resilience to cell death could be therapeutically harnessed to improve kidney repair

In the battle of the sexes, women beat men in their ability to recover from kidney injury, but the reasons are not well understood.

8 Nov 2022

Poor sleep increases the risk of glaucoma

Snoring, daytime sleepiness, insomnia, and sleep duration may increase the risk of glaucoma.

8 Nov 2022

Study shows the added value of genetic information in measuring inherited disease risk

A new study from the University of Helsinki demonstrates the added value of genetic information in measuring inherited disease risk, alongside the widely used assessment of family history.

8 Nov 2022

Hormone plays vital role in early prediction of age-related morbidity in men

Researchers have discovered the vital role of a hormone, that develops in men during puberty, in providing an early prediction of whether they could develop certain diseases in later life.

8 Nov 2022

Study highlights the need for early and timely diagnosis of type 1 diabetes in children and adolescents

If children and young people have already developed metabolic imbalances (diabetic ketoacidosis) at the time of diagnosis of type 1 diabetes (T1D), this can result in complications such as extended stays in hospital, poorer long-term control of blood sugar levels, brain edema, or even a higher mortality rate.

8 Nov 2022

Researchers unravel genetic changes in a region that controls the activity of the genome

Scientists have discovered the cause of a rare condition within a part of the genome that has been largely unexplored in medical genetics. A team at the University of Exeter has found genetic changes in a region that controls the activity of the genome, turning on or off genes, and in doing so they have found a key that could unlock other causes of rare conditions.

8 Nov 2022

Low-protein highly processed foods lead to higher energy intake

A year-long study of the dietary habits of 9,341 Australians has backed growing evidence that highly processed and refined foods are the leading contributor of rising obesity rates in the Western world.

8 Nov 2022

Novel biomarker for the prediction of age-linked disease

Researchers have discovered the vital role of a hormone, that develops in men during puberty, in providing an early prediction of whether they could develop certain diseases in later life.

8 Nov 2022

Study: Fenofibrate not a useful strategy for decreasing COVID-19 severity

After showing promise in early laboratory research, the cholesterol-lowering drug fenofibrate had no significant effect on COVID-19 outcomes in a multicenter international randomized clinical trial led by Penn Medicine scientists.

8 Nov 2022

Restoring blood flow to the legs reduces pain, improves quality of life for people with peripheral artery disease

Restoring blood flow to the legs, whether through bypass surgery or a less invasive artery-opening procedure with a stent, reduced pain and improved quality of life for people with peripheral artery disease (PAD), according to preliminary, late-breaking research presented today at the American Heart Association's Scientific Sessions 2022.

7 Nov 2022

Bypass surgery linked to fewer amputations in people with severe peripheral artery disease

People with severe peripheral artery disease, or PAD, who received bypass surgery to improve blood flow to their legs and feet had 65 percent fewer repeat procedures and 27% fewer amputations than those who had minimally invasive procedures such as angioplasty and stenting, according to preliminary late-breaking research presented today at the American Heart Association's Scientific Sessions 2022.

7 Nov 2022

SGLT-2 inhibitors reduce cardiovascular risk among patients with chronic kidney disease

SGLT-2 inhibitors, a type of diabetes medicine, decreased cardiovascular risk among adults with chronic kidney disease, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2022.

7 Nov 2022

New medication lowers triglyceride levels, yet does not decrease cardiovascular risk in people with Type 2 diabetes

A new medication, pemafibrate, lowered triglyceride levels among adults with Type 2 diabetes yet did not decrease their cardiovascular risk, according to late-breaking science research presented today at the American Heart Association's Scientific Sessions 2022.

7 Nov 2022

Personalized 'precision' testing approach leads to efficient chest pain evaluations for heart disease risk

For people with stable chest pain, a personalized "precision" testing approach led to more efficient evaluations for heart disease risk and improved diagnosis and treatment of coronary artery disease when compared to usual care, according to late-breaking science presented today at the American Heart Association's Scientific Sessions 2022.

7 Nov 2022

COVID-19 amplifies damage to the central nervous system in Alzheimer's disease

In a recent study published in the journal Annals of Diagnostic Pathology, researchers in the United States evaluated the impact of coronavirus disease 2019 (COVID-19) on central nervous system (CNS) damage in Alzheimer's disease (AD).

7 Nov 2022

High-intensity treatment strategy for heart failure reduces the risk of death or hospital readmission

Ramping up medication doses quickly after being hospitalized for acute heart failure resulted in a lower risk of dying or being readmitted for heart failure within the first six months after discharge, compared to usual care, according to a featured science research presentation today at the American Heart Association's Scientific Sessions 2022.

7 Nov 2022

Paxlovid antiviral therapy reduces risk of long COVID

In a recent study posted to the medRxiv* server, researchers in Saint Louis, Missouri, examined whether nirmatrelvir treatment reduced the risk of long COVID, the disease encompassing the post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [PASC].

7 Nov 2022

Exercise program improves insulin action in the brain

If the brain no longer responds correctly to the hormone insulin (insulin resistance), this also has a negative effect on the metabolism in the body and the regulation of eating behavior.

7 Nov 2022

Diabetes News and Research

Latest Diabetes News and Research

Food sustainability incorporated in only 20% of European food-based dietary guidelines

Study helps understand the basis of sex differences in SARS-CoV-2 infection

Female resilience to cell death could be therapeutically harnessed to improve kidney repair

Poor sleep increases the risk of glaucoma

Study shows the added value of genetic information in measuring inherited disease risk

Hormone plays vital role in early prediction of age-related morbidity in men

Study highlights the need for early and timely diagnosis of type 1 diabetes in children and adolescents

Researchers unravel genetic changes in a region that controls the activity of the genome

Low-protein highly processed foods lead to higher energy intake

Novel biomarker for the prediction of age-linked disease

Study: Fenofibrate not a useful strategy for decreasing COVID-19 severity

Restoring blood flow to the legs reduces pain, improves quality of life for people with peripheral artery disease

Bypass surgery linked to fewer amputations in people with severe peripheral artery disease

SGLT-2 inhibitors reduce cardiovascular risk among patients with chronic kidney disease

New medication lowers triglyceride levels, yet does not decrease cardiovascular risk in people with Type 2 diabetes

Personalized 'precision' testing approach leads to efficient chest pain evaluations for heart disease risk

COVID-19 amplifies damage to the central nervous system in Alzheimer's disease

High-intensity treatment strategy for heart failure reduces the risk of death or hospital readmission

Paxlovid antiviral therapy reduces risk of long COVID

Exercise program improves insulin action in the brain

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Diabetes News and Research

Latest Diabetes News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in